HU9603068D0 - Novel tetrapeptides, their manufacture and use - Google Patents

Novel tetrapeptides, their manufacture and use

Info

Publication number
HU9603068D0
HU9603068D0 HU9603068A HU9603068A HU9603068D0 HU 9603068 D0 HU9603068 D0 HU 9603068D0 HU 9603068 A HU9603068 A HU 9603068A HU 9603068 A HU9603068 A HU 9603068A HU 9603068 D0 HU9603068 D0 HU 9603068D0
Authority
HU
Hungary
Prior art keywords
manufacture
tetrapeptides
novel
novel tetrapeptides
compounds
Prior art date
Application number
HU9603068A
Other languages
English (en)
Other versions
HUT75709A (en
HU220862B1 (en
Inventor
Wilhelm Amberg
Harald Bernard
Ernst Buschmann
Potzolli Bernd De
Andreas Haupt
Lothar Janitschke
Bernd Janssen
Ulrich Karl
Andreas Kling
Stefan Mueller
Kurt Ritter
Marco Thyes
Thomas Zierke
Original Assignee
Basf Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basf Ag filed Critical Basf Ag
Publication of HU9603068D0 publication Critical patent/HU9603068D0/hu
Publication of HUT75709A publication Critical patent/HUT75709A/hu
Publication of HU220862B1 publication Critical patent/HU220862B1/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
    • C07K5/101—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms, e.g. Val, Ile, Leu
HU9603068A 1994-05-06 1995-04-26 Tetrapeptides, tetrapeptide salts and process for their preparation HU220862B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4415998A DE4415998A1 (de) 1994-05-06 1994-05-06 Neue Tetrapeptide, ihre Herstellung Verwendung
PCT/EP1995/001576 WO1995030690A1 (de) 1994-05-06 1995-04-26 Neue tetrapeptide, ihre herstellung und verwendung

Publications (3)

Publication Number Publication Date
HU9603068D0 true HU9603068D0 (en) 1997-01-28
HUT75709A HUT75709A (en) 1997-05-28
HU220862B1 HU220862B1 (en) 2002-06-29

Family

ID=6517454

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9603068A HU220862B1 (en) 1994-05-06 1995-04-26 Tetrapeptides, tetrapeptide salts and process for their preparation

Country Status (13)

Country Link
US (2) US5886147A (hu)
EP (1) EP0804466B1 (hu)
JP (1) JP4452329B2 (hu)
KR (1) KR970702879A (hu)
AT (1) ATE174035T1 (hu)
AU (1) AU2408295A (hu)
CA (1) CA2189691C (hu)
DE (2) DE4415998A1 (hu)
ES (1) ES2126279T3 (hu)
FI (1) FI119641B (hu)
HU (1) HU220862B1 (hu)
MX (1) MX9605400A (hu)
WO (1) WO1995030690A1 (hu)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW474946B (en) * 1995-12-15 2002-02-01 Basf Ag Novel compounds, the preparation and use thereof
US20010009901A1 (en) 1996-12-11 2001-07-26 Basf Aktiengesellschaft Germany Antineoplastic peptides
EP2266607A3 (en) 1999-10-01 2011-04-20 Immunogen, Inc. Immunoconjugates for treating cancer
US6203412B1 (en) * 1999-11-19 2001-03-20 Chartered Semiconductor Manufacturing Ltd. Submerge chemical-mechanical polishing
KR20020066476A (ko) * 2001-02-12 2002-08-19 쥬가이 세이야쿠 가부시키가이샤 펩타이드 유도체의 제조방법
AU2011215900A1 (en) 2010-02-10 2012-07-26 Immunogen, Inc. CD20 antibodies and uses thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4978744A (en) * 1989-01-27 1990-12-18 Arizona Board Of Regents Synthesis of dolastatin 10
US4879278A (en) * 1989-05-16 1989-11-07 Arizona Board Of Regents Isolation and structural elucidation of the cytostatic linear depsipeptide dolastatin 15
UA45304C2 (uk) * 1992-05-20 2002-04-15 Басф Аг Похідні пептиду або їх солі, фармацевтична композиція
DE4415997A1 (de) * 1994-05-06 1995-11-09 Basf Ag Neuer peptidischer Wirkstoff und dessen Herstellung

Also Published As

Publication number Publication date
WO1995030690A1 (de) 1995-11-16
FI119641B (fi) 2009-01-30
AU2408295A (en) 1995-11-29
EP0804466A1 (de) 1997-11-05
US5886147A (en) 1999-03-23
DE59504450D1 (de) 1999-01-14
JPH09512802A (ja) 1997-12-22
CA2189691A1 (en) 1995-11-16
KR970702879A (ko) 1997-06-10
US6248865B1 (en) 2001-06-19
FI964446A (fi) 1997-01-03
ES2126279T3 (es) 1999-03-16
JP4452329B2 (ja) 2010-04-21
ATE174035T1 (de) 1998-12-15
EP0804466B1 (de) 1998-12-02
FI964446A0 (fi) 1996-11-05
HUT75709A (en) 1997-05-28
CA2189691C (en) 2011-02-15
DE4415998A1 (de) 1995-11-09
MX9605400A (es) 1997-12-31
HU220862B1 (en) 2002-06-29

Similar Documents

Publication Publication Date Title
SE9704546D0 (sv) Novel compounds
IL128231A0 (en) Novel benzamidines
EP0636617A3 (de) Verfahren zur Herstellung von N-(2-Hydroxyethyl)-piperazin.
MX9709240A (es) Fenilpiridazinonas.
ZA9811586B (en) Process for the synthesis of 1,3-diols
MY118828A (en) Substituted amino compounds and their use as substances having an analgesic effect
CA2160961A1 (fr) Nouveaux composes amides tricycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
AU3220995A (en) Anthracyclinone derivatives and their use in amyloidosis
MX9803672A (es) Nuevos derivados de fenilamidina, procedimiento para su preparacion y su utilizacion como medicamentos.
CA2111083A1 (en) Novel peptides, their preparation and use
AU1227699A (en) Oxyranyle-triazoline thiones and their use as microbicides
HU9603068D0 (en) Novel tetrapeptides, their manufacture and use
MX9601635A (es) Derivados de antraciclina.
GB2241966B (en) Process for the manufacture of paper for use as bills
IN187760B (hu)
HUP9801056A3 (en) Triazolones as apolipoprotein-b synthesis inhibitors, process for producing them, their use and pharmaceutical compositions containing the same
HU9601977D0 (en) Mixtures containing amino acides and dipeptides, process for producing the dipeptides, and pharmaceutical compositions containing these mixtures and/or dipeptides
TW224461B (hu)
ZA986336B (en) Medicaments comprising polyhydroxybutylpyrazines novel polyhydroxybutylpyrazines and their preparation
DE3064069D1 (en) (-)-alpha-(2-(bis(1-methylethyl)amino)ethyl)-alpha-phenyl-2-pyridineacetamide and pharmacologically acceptable salts thereof, process for the production thereof and compositions containing the same
AU2886595A (en) Technetium-sulphonamide complexes, their use, pharmaceutical agents containing the latter, as well as process for the production of the complexes and agents
AU8931591A (en) Pyridyl-pyrimidin-derivates, process for producing the same, agents containing the same and their use as fungicides
AU4944097A (en) Sulfonyl benzazolones
TW334424B (en) L-arginine aldehyde derivatives process for preparing them and pharmaceutical composition
MY113450A (en) Anellated b-carbolines

Legal Events

Date Code Title Description
HPC4 Succession in title of patentee

Owner name: ABBOTT GMBH & CO. KG, DE

GB9A Succession in title

Owner name: ABBVIE DEUTSCHLAND GMBH & CO KG, DE

Free format text: FORMER OWNER(S): BASF AG., DE; ABBOTT GMBH & CO. KG, DE